Colgate-Palmolive (CL) Financials

$94.31 -0.67 (-0.70%)

Closing price 03:59 PM Eastern

Extended Trading

$95.22 +0.90 (+0.96%)

As of 04:37 PM Eastern

Annual Income Statements for Colgate-Palmolive

This table shows Colgate-Palmolive's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	1,384	2,441	2,024	2,400	2,367	2,695	2,166	1,785	2,300	2,889
Consolidated Net Income / (Loss)	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049
Net Income / (Loss) Continuing Operations	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049
Total Pre-Tax Income	2,763	3,738	3,487	3,464	3,301	3,647	3,087	2,660	3,392	3,956
Total Operating Income	2,789	3,955	3,707	3,694	3,554	3,885	3,332	2,893	3,984	4,268
Total Gross Profit	9,399	9,123	9,280	9,231	9,325	10,017	10,375	10,248	11,326	12,161
Total Revenue	16,034	15,195	15,454	15,544	15,693	16,471	17,421	17,967	19,457	20,101
Operating Revenue	16,034	15,195	15,454	15,544	15,693	16,471	17,421	17,967	19,457	20,101
Total Cost of Revenue	6,635	6,072	6,174	6,313	6,368	6,454	7,046	7,719	8,131	7,940
Operating Cost of Revenue	6,635	6,072	6,174	6,313	6,368	6,454	7,046	7,719	8,131	7,940
Total Operating Expenses	6,610	5,168	5,573	5,537	5,771	6,132	7,043	7,355	7,342	7,893
Selling, General & Admin Expense	5,464	5,143	5,400	5,389	5,575	6,019	6,407	6,565	7,151	7,729
Other Operating Expenses / (Income)	1,146	25	173	148	196	113	65	69	191	164
Impairment Charge	-	-	-	-	0.00	0.00	571	721	0.00	0.00
Total Other Income / (Expense), net	-26	-217	-220	-230	-253	-238	-245	-233	-592	-312
Interest Expense	26	99	220	143	145	164	175	167	287	292
Interest & Investment Income	-	-	-	-	-	-	-	14	55	67
Other Income / (Expense), net	-	-118	-	-87	-108	-74	-70	-80	-360	-87
Income Tax Expense	1,215	1,152	1,313	906	774	787	749	693	937	907
Net Income / (Loss) Attributable to Noncontrolling Interest	164	145	150	158	160	165	172	182	155	160
Basic Earnings per Share	$1.53	$2.74	$2.30	$2.76	$2.76	$3.15	$2.56	$2.13	$2.78	$3.53
Weighted Average Basic Shares Outstanding	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Diluted Earnings per Share	$1.52	$2.72	$2.28	$2.75	$2.75	$3.14	$2.55	$2.13	$2.77	$3.51
Weighted Average Diluted Shares Outstanding	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Weighted Average Basic & Diluted Shares Outstanding	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Cash Dividends to Common per Share	-	-	$1.59	$1.66	$1.71	$1.75	$1.79	$1.86	$1.91	$2.48

This table shows Colgate-Palmolive's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	618	5.00	372	502	708	718	683	731	737	738
Consolidated Net Income / (Loss)	682	43	414	534	747	760	729	767	776	777
Net Income / (Loss) Continuing Operations	682	43	414	534	747	760	729	767	776	777
Total Pre-Tax Income	892	132	561	887	956	988	967	1,010	986	993
Total Operating Income	947	202	909	974	1,029	1,072	1,047	1,092	1,065	1,064
Total Gross Profit	2,548	2,574	2,712	2,787	2,877	2,950	3,039	3,066	3,074	2,982
Total Revenue	4,455	4,629	4,770	4,822	4,915	4,950	5,065	5,058	5,033	4,945
Operating Revenue	4,455	4,629	4,770	4,822	4,915	4,950	5,065	5,058	5,033	4,945
Total Cost of Revenue	1,907	2,055	2,058	2,035	2,038	2,000	2,026	1,992	1,959	1,963
Operating Cost of Revenue	1,907	2,055	2,058	2,035	2,038	2,000	2,026	1,992	1,959	1,963
Total Operating Expenses	1,601	2,372	1,803	1,813	1,848	1,878	1,992	1,974	2,009	1,918
Selling, General & Admin Expense	1,634	1,633	1,758	1,768	1,822	1,803	1,916	1,939	1,979	1,895
Other Operating Expenses / (Income)	-33	18	45	45	26	75	76	35	30	23
Total Other Income / (Expense), net	-55	-70	-348	-87	-73	-84	-80	-82	-79	-71
Interest Expense	40	69	54	29	-	-	58	22	23	189
Income Tax Expense	210	89	147	353	209	228	238	243	210	216
Net Income / (Loss) Attributable to Noncontrolling Interest	64	38	42	32	39	42	46	36	39	39
Basic Earnings per Share	$0.74	-	$0.45	$0.61	$0.86	$0.86	$0.83	$0.89	$0.90	$0.91
Weighted Average Basic Shares Outstanding	835.21M	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M
Diluted Earnings per Share	$0.74	$0.01	$0.45	$0.60	$0.86	$0.86	$0.83	$0.89	$0.90	$0.89
Weighted Average Diluted Shares Outstanding	835.21M	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M
Weighted Average Basic & Diluted Shares Outstanding	835.21M	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-119	345	133	-793	157	5.00	-56	-57	191	130
Net Cash From Operating Activities	2,949	3,141	3,054	3,056	3,133	3,719	3,325	2,556	3,745	4,107
Net Cash From Continuing Operating Activities	2,949	3,141	3,054	3,056	3,133	3,719	3,325	2,556	3,745	4,107
Net Income / (Loss) Continuing Operations	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049
Consolidated Net Income / (Loss)	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049
Depreciation Expense	449	443	475	511	519	539	556	545	567	605
Non-Cash Adjustments To Reconcile Net Income	1,125	-36	137	115	5.00	59	760	848	366	186
Changes in Operating Assets and Liabilities, net	-173	148	268	-128	82	261	-329	-804	357	267
Net Cash From Investing Activities	-685	-499	-471	-1,170	-2,099	-779	-592	-1,601	-742	-534
Net Cash From Continuing Investing Activities	-685	-499	-471	-1,170	-2,099	-779	-592	-1,601	-742	-534
Purchase of Property, Plant & Equipment	-691	-593	-553	-436	-335	-410	-567	-696	-705	-561
Acquisitions	-13	-5.00	0.00	-728	-1,711	-353	0.00	-809	0.00	0.00
Purchase of Investments	-742	-336	-347	-169	-184	-143	-141	-470	-506	-574
Sale of Property, Plant & Equipment	0.00	60	-	-	-	0.00	0.00	47	0.00	0.00
Sale and/or Maturity of Investments	599	378	391	156	131	124	141	322	502	564
Other Investing Activities, net	-68	-3.00	-6.00	7.00	0.00	3.00	-25	5.00	-33	37
Net Cash From Financing Activities	-2,276	-2,233	-2,450	-2,679	-870	-2,919	-2,774	-952	-2,793	-3,389
Net Cash From Continuing Financing Activities	-2,276	-2,233	-2,450	-2,679	-870	-2,919	-2,774	-952	-2,793	-3,389
Repayment of Debt	-9,181	-7,274	-4,808	-725	-1,426	-564	-898	116	-1,791	-410
Repurchase of Common Equity	-1,551	-1,335	-1,399	-1,238	-1,202	-1,476	-1,320	-1,308	-1,128	-1,739
Payment of Dividends	-1,493	-1,508	-1,529	-1,591	-1,614	-1,753	-1,679	-1,691	-1,749	-1,789
Issuance of Debt	9,602	7,438	4,779	546	2,874	0.00	699	1,513	1,495	-89
Other Financing Activities, net	347	446	507	329	498	874	424	418	380	638
Effect of Exchange Rate Changes	-107	-64	-	-	-7.00	-16	-15	-60	-19	-54
Cash Interest Paid	131	162	150	194	185	188	194	151	280	302
Cash Income Taxes Paid	1,259	932	1,037	847	803	845	890	945	937	933

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	80	-163	92	-48	132	15	113	31	124	-138
Net Cash From Operating Activities	969	673	735	722	1,152	1,136	681	990	1,167	1,269
Net Cash From Continuing Operating Activities	969	673	735	722	1,152	1,136	681	990	1,167	1,269
Net Income / (Loss) Continuing Operations	682	43	414	534	747	760	729	766	775	779
Consolidated Net Income / (Loss)	682	43	414	534	747	760	729	766	775	779
Depreciation Expense	134	135	128	145	144	150	150	157	150	148
Non-Cash Adjustments To Reconcile Net Income	-9.00	739	274	22	51	19	49	42	71	24
Changes in Operating Assets and Liabilities, net	162	-244	-81	21	210	207	-247	25	171	318
Net Cash From Investing Activities	-946	-173	-264	-174	-161	-143	-193	-111	-150	-80
Net Cash From Continuing Investing Activities	-946	-173	-264	-174	-161	-143	-193	-111	-150	-80
Purchase of Property, Plant & Equipment	-175	-221	-163	-184	-161	-197	-126	-117	-134	-184
Purchase of Investments	-113	-231	-112	-113	-99	-182	-139	-104	-115	-216
Sale and/or Maturity of Investments	20	267	14	132	118	238	78	100	82	304
Other Investing Activities, net	2.00	4.00	-3.00	-9.00	-19	-2.00	-6.00	10	17	16
Net Cash From Financing Activities	99	-666	-375	-580	-846	-992	-361	-845	-904	-1,279
Net Cash From Continuing Financing Activities	99	-666	-375	-580	-846	-992	-361	-845	-904	-1,279
Repayment of Debt	-1,066	212	-1,422	109	-184	-294	205	-12	-357	-246
Repurchase of Common Equity	-104	-413	-180	-371	-332	-245	-509	-480	-295	-455
Payment of Dividends	-392	-485	-390	-457	-396	-506	-394	-473	-408	-514
Issuance of Debt	1,499	-	1,495	2.00	-	-2.00	1.00	1.00	-	-91
Other Financing Activities, net	162	20	122	137	66	55	336	119	156	27
Effect of Exchange Rate Changes	-42	3.00	-4.00	-16	-13	14	-14	-3.00	11	-48
Cash Interest Paid	39	47	94	35	114	37	123	38	106	35
Cash Income Taxes Paid	213	255	171	279	276	211	150	355	257	171

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	11,935	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046
Total Current Assets	4,384	4,338	4,639	3,793	4,179	4,338	4,397	5,113	5,279	5,317
Cash & Equivalents	970	1,315	1,535	726	883	888	832	775	966	1,096
Accounts Receivable	1,427	1,411	1,480	1,400	1,440	1,264	1,297	1,504	1,586	1,521
Inventories, net	1,180	1,171	1,221	1,250	1,400	1,673	1,692	2,074	1,934	1,987
Other Current Assets	807	441	403	417	456	513	576	760	793	713
Plant, Property, & Equipment, net	3,796	3,840	4,072	3,881	3,750	3,716	3,730	4,307	4,582	4,422
Total Noncurrent Assets	3,755	3,945	3,965	4,487	7,105	7,866	6,913	6,311	6,532	6,307
Goodwill	2,103	2,107	2,218	2,530	3,508	3,824	3,284	3,352	3,410	3,272
Intangible Assets	1,346	1,313	1,341	1,637	2,667	2,894	2,462	1,920	1,887	1,756
Noncurrent Deferred & Refundable Income Taxes	67	301	188	152	177	291	193	135	214	195
Other Noncurrent Operating Assets	239	224	218	168	753	857	974	904	1,021	1,084
Total Liabilities & Shareholders' Equity	11,935	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046
Total Liabilities	11,979	12,106	12,433	11,964	14,476	14,819	14,069	14,925	15,436	15,502
Total Current Liabilities	3,534	3,305	3,408	3,341	4,038	4,404	4,051	4,004	4,741	5,759
Short-Term Debt	302	13	11	12	514	267	51	25	330	660
Accounts Payable	1,110	1,124	1,212	1,222	1,237	1,393	1,479	1,551	1,698	1,805
Accrued Expenses	1,845	1,727	1,831	1,696	1,917	2,341	2,085	2,111	2,377	2,891
Current Deferred & Payable Income Tax Liabilities	277	441	354	411	370	403	436	317	336	403
Total Noncurrent Liabilities	8,445	8,801	9,025	8,623	10,438	10,415	10,018	10,921	10,695	9,743
Long-Term Debt	6,246	6,520	6,566	6,354	7,333	7,334	7,194	8,741	8,219	7,289
Noncurrent Deferred & Payable Income Tax Liabilities	233	246	204	235	507	426	395	383	361	343
Other Noncurrent Operating Liabilities	1,966	2,035	2,255	2,034	2,598	2,655	2,429	1,797	2,115	2,111
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-44	17	243	197	558	1,101	971	806	957	544
Total Preferred & Common Equity	-299	-243	-60	-102	117	743	609	401	609	212
Total Common Equity	-299	-243	-60	-102	117	743	609	401	609	212
Common Stock	2,904	3,157	3,450	3,670	3,954	4,435	4,735	5,012	5,274	5,647
Retained Earnings	18,861	19,922	20,531	21,615	22,501	23,699	24,350	24,573	25,289	26,145
Treasury Stock	-18,102	-19,135	-20,181	-21,196	-22,063	-23,045	-24,089	-25,128	-26,017	-27,358
Accumulated Other Comprehensive Income / (Loss)	-3,950	-4,180	-3,855	-4,188	-4,273	-4,345	-4,386	-4,055	-3,937	-4,222
Noncontrolling Interest	255	260	303	299	441	358	362	405	348	332

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	16,288	15,731	16,173	16,227	16,043	16,393	16,571	16,480	16,774	16,046
Total Current Assets	5,278	5,113	5,466	5,437	5,357	5,279	5,640	5,646	5,806	5,317
Cash & Equivalents	938	775	867	819	951	966	1,079	1,110	1,234	1,096
Accounts Receivable	1,425	1,504	1,590	1,656	1,577	1,586	1,813	1,825	1,712	1,521
Inventories, net	2,073	2,074	2,110	2,039	1,931	1,934	1,914	1,922	2,041	1,987
Other Current Assets	842	760	899	923	898	793	834	789	819	713
Plant, Property, & Equipment, net	4,123	4,307	4,363	4,431	4,409	4,582	4,497	4,392	4,421	4,422
Total Noncurrent Assets	6,887	6,311	6,344	6,359	6,277	6,532	6,434	6,442	6,547	6,307
Goodwill	3,538	3,352	3,375	3,373	3,327	3,410	3,341	3,320	3,389	3,272
Intangible Assets	2,219	1,920	1,918	1,901	1,861	1,887	1,837	1,814	1,834	1,756
Noncurrent Deferred & Refundable Income Taxes	182	135	179	186	202	214	222	214	219	195
Other Noncurrent Operating Assets	948	904	872	899	887	1,021	1,034	1,094	1,105	1,084
Total Liabilities & Shareholders' Equity	16,288	15,731	16,173	16,227	16,043	16,393	16,571	16,480	16,774	16,046
Total Liabilities	15,235	14,925	15,748	15,912	15,637	15,436	15,954	15,998	15,938	15,502
Total Current Liabilities	4,492	4,004	4,441	4,632	4,602	4,741	5,314	5,350	5,565	5,759
Short-Term Debt	29	25	37	35	34	330	538	530	527	660
Accounts Payable	1,541	1,551	1,609	1,544	1,482	1,698	1,646	1,557	1,625	1,805
Accrued Expenses	2,489	2,111	2,498	2,600	2,732	2,377	2,720	2,864	3,066	2,891
Current Deferred & Payable Income Tax Liabilities	433	317	297	453	354	336	410	399	347	403
Total Noncurrent Liabilities	10,743	10,921	11,307	11,280	11,035	10,695	10,640	10,648	10,373	9,743
Long-Term Debt	8,219	8,741	8,870	8,954	8,690	8,219	8,151	8,146	7,909	7,289
Noncurrent Deferred & Payable Income Tax Liabilities	551	383	421	363	430	361	392	355	320	343
Other Noncurrent Operating Liabilities	1,973	1,797	2,016	1,963	1,915	2,115	2,097	2,147	2,144	2,111
Commitments & Contingencies	-	0.00	-	-	-	0.00	-	-	-	0.00
Total Equity & Noncontrolling Interests	1,053	806	425	315	406	957	617	482	836	544
Total Preferred & Common Equity	622	401	-6.00	-64	-9.00	609	230	123	435	212
Total Common Equity	622	401	-6.00	-64	-9.00	609	230	123	435	212
Common Stock	4,984	5,012	5,069	5,154	5,228	5,274	5,428	5,501	5,608	5,647
Retained Earnings	24,566	24,573	24,153	24,258	24,571	25,289	25,164	25,486	25,814	26,145
Treasury Stock	-24,749	-25,128	-25,245	-25,541	-25,834	-26,017	-26,343	-26,736	-26,913	-27,358
Accumulated Other Comprehensive Income / (Loss)	-4,179	-4,055	-3,983	-3,935	-3,974	-3,937	-4,019	-4,128	-4,074	-4,222
Noncontrolling Interest	431	405	431	379	415	348	387	359	401	332

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.19%	-5.23%	1.70%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%
EBITDA Growth	-19.03%	32.18%	-2.29%	-1.53%	-3.72%	9.71%	-12.23%	-12.05%	24.81%	14.20%
EBIT Growth	-21.59%	37.58%	-3.39%	-2.70%	-4.46%	10.59%	-14.41%	-13.76%	28.83%	15.37%
NOPAT Growth	-33.65%	75.10%	-15.53%	18.03%	-0.26%	11.98%	-17.17%	-15.23%	34.79%	14.08%
Net Income Growth	-33.82%	67.05%	-15.93%	17.66%	-1.21%	13.18%	-18.25%	-15.87%	24.81%	24.20%
EPS Growth	-35.59%	78.95%	-16.18%	20.61%	0.00%	14.18%	-18.79%	-16.47%	30.05%	26.71%
Operating Cash Flow Growth	-10.58%	6.51%	-2.77%	0.07%	2.52%	18.70%	-10.59%	-23.13%	46.52%	9.67%
Free Cash Flow Firm Growth	-21.30%	22.75%	-25.50%	-3.77%	-52.40%	165.97%	7.22%	-75.41%	332.39%	41.14%
Invested Capital Growth	-14.12%	-5.40%	0.96%	10.44%	28.87%	3.88%	-5.50%	19.14%	-2.92%	-13.38%
Revenue Q/Q Growth	-1.97%	-1.16%	1.12%	-0.52%	1.32%	1.91%	0.46%	1.27%	1.68%	-0.02%
EBITDA Q/Q Growth	-25.95%	34.42%	-2.47%	-3.54%	-1.52%	-0.68%	-14.95%	-4.74%	14.32%	-1.99%
EBIT Q/Q Growth	-28.91%	39.88%	-2.96%	-4.15%	-1.94%	-0.94%	-17.12%	-5.38%	16.38%	-2.22%
NOPAT Q/Q Growth	-41.05%	72.50%	-12.92%	12.76%	1.54%	0.68%	-17.50%	-5.47%	35.11%	0.25%
Net Income Q/Q Growth	-41.25%	68.25%	-11.23%	12.79%	1.57%	0.35%	-17.73%	-6.87%	41.25%	0.56%
EPS Q/Q Growth	-44.73%	76.62%	-11.97%	13.64%	1.85%	0.32%	-18.79%	-6.99%	44.27%	0.86%
Operating Cash Flow Q/Q Growth	-2.16%	-0.54%	-2.08%	3.49%	3.57%	-0.19%	4.49%	-14.49%	14.11%	3.35%
Free Cash Flow Firm Q/Q Growth	-21.79%	46.76%	-16.03%	1.77%	3.84%	-10.66%	13.00%	-56.38%	35.47%	29.51%
Invested Capital Q/Q Growth	-6.76%	-4.00%	-2.38%	2.49%	1.97%	6.75%	-4.91%	5.19%	4.41%	-7.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.62%	60.04%	60.05%	59.39%	59.42%	60.82%	59.55%	57.04%	58.21%	60.50%
EBITDA Margin	20.19%	28.17%	27.06%	26.49%	25.27%	26.41%	21.92%	18.69%	21.54%	23.81%
Operating Margin	17.39%	26.03%	23.99%	23.76%	22.65%	23.59%	19.13%	16.10%	20.48%	21.23%
EBIT Margin	17.39%	25.25%	23.99%	23.21%	21.96%	23.14%	18.72%	15.66%	18.63%	20.80%
Profit (Net Income) Margin	9.65%	17.02%	14.07%	16.46%	16.10%	17.36%	13.42%	10.95%	12.62%	15.17%
Tax Burden Percent	56.03%	69.18%	62.35%	73.85%	76.55%	78.42%	75.74%	73.95%	72.38%	77.07%
Interest Burden Percent	99.07%	97.42%	94.07%	96.04%	95.79%	95.70%	94.64%	94.56%	93.60%	94.62%
Effective Tax Rate	43.97%	30.82%	37.65%	26.15%	23.45%	21.58%	24.26%	26.05%	27.62%	22.93%
Return on Invested Capital (ROIC)	26.09%	50.81%	43.94%	49.05%	40.73%	39.73%	33.21%	26.44%	33.26%	41.28%
ROIC Less NNEP Spread (ROIC-NNEP)	25.82%	48.03%	41.26%	45.87%	37.66%	37.00%	30.38%	24.05%	27.76%	37.95%
Return on Net Nonoperating Assets (RNNOA)	204.78%	-19,206.37%	1,628.37%	1,113.67%	628.67%	305.05%	192.47%	194.94%	245.24%	364.98%
Return on Equity (ROE)	230.87%	-19,155.56%	1,672.31%	1,162.73%	669.40%	344.79%	225.68%	221.38%	278.50%	406.26%
Cash Return on Invested Capital (CROIC)	41.29%	56.37%	42.99%	39.13%	15.51%	35.92%	38.87%	8.98%	36.23%	55.62%
Operating Return on Assets (OROA)	21.97%	31.90%	29.90%	29.05%	25.34%	24.62%	21.07%	18.28%	22.56%	25.78%
Return on Assets (ROA)	12.19%	21.50%	17.53%	20.60%	18.58%	18.48%	15.10%	12.78%	15.28%	18.80%
Return on Common Equity (ROCE)	145.65%	-384,530.04%	-1,948.88%	-428.10%	13.30%	178.73%	147.26%	125.83%	159.55%	222.21%
Return on Equity Simple (ROE_SIMPLE)	-517.73%	-1,064.20%	-3,623.33%	-2,507.84%	2,159.83%	384.93%	383.91%	490.52%	403.12%	1,438.21%
Net Operating Profit after Tax (NOPAT)	1,563	2,736	2,311	2,728	2,721	3,047	2,524	2,139	2,883	3,289
NOPAT Margin	9.75%	18.01%	14.96%	17.55%	17.34%	18.50%	14.49%	11.91%	14.82%	16.36%
Net Nonoperating Expense Percent (NNEP)	0.27%	2.78%	2.67%	3.18%	3.07%	2.73%	2.83%	2.39%	5.50%	3.33%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	22.35%	30.33%	38.73%
Cost of Revenue to Revenue	41.38%	39.96%	39.95%	40.61%	40.58%	39.18%	40.45%	42.96%	41.79%	39.50%
SG&A Expenses to Revenue	34.08%	33.85%	34.94%	34.67%	35.53%	36.54%	36.78%	36.54%	36.75%	38.45%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	41.22%	34.01%	36.06%	35.62%	36.77%	37.23%	40.43%	40.94%	37.73%	39.27%
Earnings before Interest and Taxes (EBIT)	2,789	3,837	3,707	3,607	3,446	3,811	3,262	2,813	3,624	4,181
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,238	4,280	4,182	4,118	3,965	4,350	3,818	3,358	4,191	4,786
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	455.60	91.25	111.74	155.64	104.85	348.38
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.07	3.22	3.69	2.93	3.40	4.12	3.91	3.47	3.28	3.67
Price to Earnings (P/E)	35.52	20.05	28.16	18.95	22.52	25.16	31.42	34.96	27.76	25.56
Dividend Yield	2.74%	2.82%	2.45%	3.17%	2.75%	2.21%	2.22%	2.49%	2.46%	2.19%
Earnings Yield	2.82%	4.99%	3.55%	5.28%	4.44%	3.98%	3.18%	2.86%	3.60%	3.91%
Enterprise Value to Invested Capital (EV/IC)	9.94	10.39	11.79	8.81	8.07	9.58	10.13	8.05	8.41	10.96
Enterprise Value to Revenue (EV/Rev)	3.43	3.58	4.03	3.31	3.87	4.55	4.30	3.94	3.69	4.03
Enterprise Value to EBITDA (EV/EBITDA)	16.98	12.71	14.91	12.49	15.31	17.21	19.60	21.09	17.13	16.93
Enterprise Value to EBIT (EV/EBIT)	19.72	14.18	16.82	14.26	17.62	19.65	22.94	25.17	19.81	19.38
Enterprise Value to NOPAT (EV/NOPAT)	35.20	19.89	26.97	18.85	22.31	24.57	29.65	33.10	24.90	24.64
Enterprise Value to Operating Cash Flow (EV/OCF)	18.65	17.32	20.41	16.83	19.38	20.13	22.50	27.70	19.17	19.73
Enterprise Value to Free Cash Flow (EV/FCFF)	22.24	17.93	27.57	23.63	58.62	27.18	25.33	97.49	22.86	18.28
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-148.82	384.29	27.07	32.31	14.06	6.90	7.46	10.88	8.93	14.61
Long-Term Debt to Equity	-141.95	383.53	27.02	32.25	13.14	6.66	7.41	10.84	8.59	13.40
Financial Leverage	7.93	-399.85	39.46	24.28	16.69	8.24	6.33	8.11	8.83	9.62
Leverage Ratio	18.94	-891.04	95.38	56.45	36.02	18.66	14.94	17.32	18.22	21.61
Compound Leverage Factor	18.76	-868.05	89.72	54.21	34.50	17.86	14.14	16.37	17.05	20.45
Debt to Total Capital	100.68%	99.74%	96.44%	97.00%	93.36%	87.35%	88.18%	91.58%	89.93%	93.59%
Short-Term Debt to Total Capital	4.64%	0.20%	0.16%	0.18%	6.12%	3.07%	0.62%	0.26%	3.47%	7.77%
Long-Term Debt to Total Capital	96.03%	99.54%	96.28%	96.82%	87.25%	84.28%	87.56%	91.32%	86.46%	85.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.92%	3.97%	4.44%	4.56%	5.25%	4.11%	4.41%	4.23%	3.66%	3.91%
Common Equity to Total Capital	-4.60%	-3.71%	-0.88%	-1.55%	1.39%	8.54%	7.41%	4.19%	6.41%	2.50%
Debt to EBITDA	2.02	1.53	1.57	1.55	1.98	1.75	1.90	2.61	2.04	1.66
Net Debt to EBITDA	1.72	1.22	1.21	1.37	1.76	1.54	1.68	2.38	1.81	1.43
Long-Term Debt to EBITDA	1.93	1.52	1.57	1.54	1.85	1.69	1.88	2.60	1.96	1.52
Debt to NOPAT	4.19	2.39	2.85	2.33	2.88	2.49	2.87	4.10	2.96	2.42
Net Debt to NOPAT	3.57	1.91	2.18	2.07	2.56	2.20	2.54	3.74	2.63	2.08
Long-Term Debt to NOPAT	4.00	2.38	2.84	2.33	2.70	2.41	2.85	4.09	2.85	2.22
Altman Z-Score	6.87	7.13	7.32	7.07	6.12	6.65	7.07	6.51	6.60	7.22
Noncontrolling Interest Sharing Ratio	36.91%	-1,907.41%	216.54%	136.82%	98.01%	48.16%	34.75%	43.16%	42.71%	45.30%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.24	1.31	1.36	1.14	1.03	0.99	1.09	1.28	1.11	0.92
Quick Ratio	0.68	0.82	0.88	0.64	0.58	0.49	0.53	0.57	0.54	0.45
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,473	3,035	2,261	2,176	1,036	2,755	2,954	726	3,140	4,432
Operating Cash Flow to CapEx	426.77%	589.31%	552.26%	700.92%	935.22%	907.07%	586.42%	393.84%	531.21%	732.09%
Free Cash Flow to Firm to Interest Expense	95.10	30.66	10.28	15.22	7.14	16.80	16.88	4.35	10.94	15.18
Operating Cash Flow to Interest Expense	113.42	31.73	13.88	21.37	21.61	22.68	19.00	15.31	13.05	14.07
Operating Cash Flow Less CapEx to Interest Expense	86.85	26.34	11.37	18.32	19.30	20.18	15.76	11.42	10.59	12.14
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.26	1.26	1.25	1.25	1.15	1.06	1.13	1.17	1.21	1.24
Accounts Receivable Turnover	10.76	10.71	10.69	10.79	11.05	12.18	13.60	12.83	12.59	12.94
Inventory Turnover	5.18	5.17	5.16	5.11	4.81	4.20	4.19	4.10	4.06	4.05
Fixed Asset Turnover	4.07	3.98	3.91	3.91	4.11	4.41	4.68	4.47	4.38	4.46
Accounts Payable Turnover	5.67	5.44	5.29	5.19	5.18	4.91	4.91	5.10	5.01	4.53
Days Sales Outstanding (DSO)	33.91	34.09	34.14	33.81	33.03	29.96	26.83	28.45	28.98	28.21
Days Inventory Outstanding (DIO)	70.47	70.66	70.71	71.43	75.95	86.90	87.16	89.04	89.96	90.12
Days Payable Outstanding (DPO)	64.39	67.15	69.05	70.36	70.47	74.37	74.39	71.64	72.92	80.52
Cash Conversion Cycle (CCC)	39.99	37.60	35.80	34.88	38.50	42.49	39.60	45.85	46.02	37.82
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,534	5,235	5,285	5,837	7,522	7,814	7,384	8,797	8,540	7,397
Invested Capital Turnover	2.68	2.82	2.94	2.80	2.35	2.15	2.29	2.22	2.24	2.52
Increase / (Decrease) in Invested Capital	-910	-299	50	552	1,685	292	-430	1,413	-257	-1,143
Enterprise Value (EV)	54,996	54,412	62,334	51,425	60,710	74,869	74,828	70,806	71,784	81,041
Market Capitalization	49,163	48,934	56,989	45,486	53,305	67,798	68,053	62,410	63,853	73,856
Book Value per Share	($0.33)	($0.27)	($0.07)	($0.12)	$0.14	$0.87	$0.72	$0.48	$0.74	$0.26
Tangible Book Value per Share	($4.18)	($4.12)	($4.12)	($4.92)	($7.07)	($6.97)	($6.09)	($5.83)	($5.69)	($5.89)
Total Capital	6,504	6,550	6,820	6,563	8,405	8,702	8,216	9,572	9,506	8,493
Total Debt	6,548	6,533	6,577	6,366	7,847	7,601	7,245	8,766	8,549	7,949
Total Long-Term Debt	6,246	6,520	6,566	6,354	7,333	7,334	7,194	8,741	8,219	7,289
Net Debt	5,578	5,218	5,042	5,640	6,964	6,713	6,413	7,991	7,583	6,853
Capital Expenditures (CapEx)	691	533	553	436	335	410	567	649	705	561
Debt-free, Cash-free Net Working Capital (DFCFNWC)	182	-269	-293	-262	-228	-687	-435	359	-98	-878
Debt-free Net Working Capital (DFNWC)	1,152	1,046	1,242	464	655	201	397	1,134	868	218
Net Working Capital (NWC)	850	1,033	1,231	452	141	-66	346	1,109	538	-442
Net Nonoperating Expense (NNE)	15	150	137	170	194	187	186	172	428	240
Net Nonoperating Obligations (NNO)	5,578	5,218	5,042	5,640	6,964	6,713	6,413	7,991	7,583	6,853
Total Depreciation and Amortization (D&A)	449	443	475	511	519	539	556	545	567	605
Debt-free, Cash-free Net Working Capital to Revenue	1.14%	-1.77%	-1.90%	-1.69%	-1.45%	-4.17%	-2.50%	2.00%	-0.50%	-4.37%
Debt-free Net Working Capital to Revenue	7.18%	6.88%	8.04%	2.99%	4.17%	1.22%	2.28%	6.31%	4.46%	1.08%
Net Working Capital to Revenue	5.30%	6.80%	7.97%	2.91%	0.90%	-0.40%	1.99%	6.17%	2.77%	-2.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.53	$2.74	$0.00	$2.76	$2.76	$3.15	$2.56	$2.13	$2.78	$3.53
Adjusted Weighted Average Basic Shares Outstanding	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Adjusted Diluted Earnings per Share	$1.52	$2.72	$0.00	$2.75	$2.75	$3.14	$2.55	$2.13	$2.77	$3.51
Adjusted Weighted Average Diluted Shares Outstanding	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Normalized Net Operating Profit after Tax (NOPAT)	1,563	2,736	2,311	2,728	2,721	3,047	2,956	2,672	2,883	3,289
Normalized NOPAT Margin	9.75%	18.01%	14.96%	17.55%	17.34%	18.50%	16.97%	14.87%	14.82%	16.36%
Pre Tax Income Margin	17.23%	24.60%	22.56%	22.29%	21.03%	22.14%	17.72%	14.80%	17.43%	19.68%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	107.27	38.76	16.85	25.22	23.77	23.24	18.64	16.84	12.63	14.32
NOPAT to Interest Expense	60.10	27.64	10.51	19.08	18.76	18.58	14.42	12.81	10.05	11.27
EBIT Less CapEx to Interest Expense	80.69	33.37	14.34	22.17	21.46	20.74	15.40	12.96	10.17	12.40
NOPAT Less CapEx to Interest Expense	33.52	22.25	7.99	16.03	16.45	16.08	11.18	8.92	7.59	9.34
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	96.45%	58.31%	70.33%	62.20%	63.87%	61.29%	71.81%	85.97%	71.24%	58.68%
Augmented Payout Ratio	196.64%	109.94%	134.68%	110.59%	111.44%	112.90%	128.27%	152.47%	117.19%	115.71%

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.93%	5.13%	8.43%	7.54%	10.33%	6.93%	6.18%	4.89%	2.40%	-0.10%
EBITDA Growth	-2.29%	-34.15%	-22.60%	10.79%	8.63%	279.50%	58.14%	11.62%	4.92%	-0.82%
EBIT Growth	-2.00%	-46.11%	-25.18%	11.70%	8.80%	473.26%	66.67%	12.12%	5.03%	-0.75%
NOPAT Growth	-6.21%	-68.93%	2.84%	-12.70%	11.05%	1,153.16%	17.66%	41.42%	4.25%	0.96%
Net Income Growth	0.15%	-77.13%	-31.34%	-16.43%	9.53%	1,667.44%	76.09%	43.63%	3.88%	2.24%
EPS Growth	-1.33%	-94.12%	-31.82%	-16.67%	16.22%	8,500.00%	84.44%	48.33%	4.65%	3.49%
Operating Cash Flow Growth	-2.52%	-39.15%	90.41%	36.74%	18.89%	68.80%	-7.35%	37.12%	1.30%	11.71%
Free Cash Flow Firm Growth	-61.45%	-309.91%	-148.35%	-124.25%	683.84%	180.29%	405.58%	695.55%	-0.90%	82.65%
Invested Capital Growth	7.70%	19.14%	13.50%	10.40%	-2.20%	-2.92%	-2.81%	-5.15%	-1.72%	-13.38%
Revenue Q/Q Growth	-0.65%	3.91%	3.05%	1.09%	1.93%	0.71%	2.32%	-0.14%	-0.49%	-1.75%
EBITDA Q/Q Growth	5.54%	-69.79%	130.75%	50.61%	3.49%	5.53%	-2.08%	6.30%	-2.72%	-0.25%
EBIT Q/Q Growth	6.88%	-79.94%	228.88%	58.37%	4.11%	5.72%	-2.38%	6.54%	-2.47%	-0.09%
NOPAT Q/Q Growth	7.80%	-90.91%	919.43%	-12.59%	37.12%	2.56%	-4.28%	5.06%	1.07%	-0.67%
Net Income Q/Q Growth	6.73%	-93.70%	862.79%	28.99%	39.89%	1.74%	-4.08%	5.21%	1.17%	0.13%
EPS Q/Q Growth	2.78%	-98.65%	4,400.00%	33.33%	43.33%	0.00%	-3.49%	7.23%	1.12%	-1.11%
Operating Cash Flow Q/Q Growth	83.52%	-30.55%	9.21%	-1.77%	59.56%	-1.39%	-40.05%	45.37%	17.88%	8.74%
Free Cash Flow Firm Q/Q Growth	-85.62%	-1,168.77%	75.05%	36.75%	564.69%	9.47%	-5.02%	23.26%	-22.67%	101.76%
Invested Capital Q/Q Growth	8.81%	5.19%	-3.77%	0.24%	-3.61%	4.41%	-3.67%	-2.18%	-0.12%	-7.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	57.19%	55.61%	56.86%	57.80%	58.54%	59.60%	60.00%	60.62%	61.08%	60.30%
EBITDA Margin	23.93%	6.96%	15.58%	23.21%	23.56%	24.69%	23.20%	24.69%	24.14%	24.51%
Operating Margin	21.26%	4.36%	19.06%	20.20%	20.94%	21.66%	20.67%	21.59%	21.16%	21.52%
EBIT Margin	20.92%	4.04%	12.89%	20.20%	20.63%	21.66%	20.24%	21.59%	21.16%	21.52%
Profit (Net Income) Margin	15.31%	0.93%	8.68%	11.07%	15.20%	15.35%	14.39%	15.16%	15.42%	15.71%
Tax Burden Percent	76.46%	32.58%	73.80%	60.20%	78.14%	76.92%	75.39%	75.94%	78.70%	78.25%
Interest Burden Percent	95.71%	70.59%	91.22%	91.07%	94.28%	92.16%	94.34%	92.49%	92.58%	93.33%
Effective Tax Rate	23.54%	67.42%	26.20%	39.80%	21.86%	23.08%	24.61%	24.06%	21.30%	21.75%
Return on Invested Capital (ROIC)	35.76%	3.16%	32.39%	28.09%	37.85%	37.39%	36.88%	39.64%	41.29%	42.47%
ROIC Less NNEP Spread (ROIC-NNEP)	35.16%	2.84%	28.91%	27.40%	37.09%	36.56%	36.11%	38.85%	40.46%	41.70%
Return on Net Nonoperating Assets (RNNOA)	237.45%	23.02%	370.40%	480.21%	383.45%	322.98%	542.34%	767.08%	487.88%	401.06%
Return on Equity (ROE)	273.20%	26.18%	402.79%	508.30%	421.30%	360.38%	579.23%	806.73%	529.18%	443.53%
Cash Return on Invested Capital (CROIC)	20.65%	8.98%	14.43%	15.50%	28.03%	36.23%	38.87%	44.57%	42.21%	55.62%
Operating Return on Assets (OROA)	23.08%	4.72%	14.83%	23.62%	24.42%	26.23%	24.41%	26.39%	25.93%	26.67%
Return on Assets (ROA)	16.89%	1.08%	9.98%	12.95%	17.99%	18.60%	17.36%	18.53%	18.89%	19.47%
Return on Common Equity (ROCE)	159.32%	14.88%	110.04%	60.55%	177.01%	206.45%	124.52%	59.72%	181.51%	242.60%
Return on Equity Simple (ROE_SIMPLE)	339.55%	0.00%	0.00%	-2,614.06%	0.00%	0.00%	1,204.35%	2,441.46%	697.01%	0.00%
Net Operating Profit after Tax (NOPAT)	724	66	671	586	804	825	789	829	838	833
NOPAT Margin	16.25%	1.42%	14.06%	12.16%	16.36%	16.66%	15.58%	16.40%	16.65%	16.84%
Net Nonoperating Expense Percent (NNEP)	0.60%	0.32%	3.48%	0.68%	0.76%	0.83%	0.77%	0.79%	0.83%	0.77%
Return On Investment Capital (ROIC_SIMPLE)	-	0.69%	-	-	-	8.67%	-	-	-	9.80%
Cost of Revenue to Revenue	42.81%	44.39%	43.14%	42.20%	41.46%	40.40%	40.00%	39.38%	38.92%	39.70%
SG&A Expenses to Revenue	36.68%	35.28%	36.86%	36.67%	37.07%	36.42%	37.83%	38.34%	39.32%	38.32%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	35.94%	51.24%	37.80%	37.60%	37.60%	37.94%	39.33%	39.03%	39.92%	38.79%
Earnings before Interest and Taxes (EBIT)	932	187	615	974	1,014	1,072	1,025	1,092	1,065	1,064
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,066	322	743	1,119	1,158	1,222	1,175	1,249	1,215	1,212
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	90.69	155.64	0.00	0.00	0.00	104.85	320.51	644.00	194.02	348.38
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.18	3.47	3.30	3.32	2.99	3.28	3.73	3.96	4.20	3.67
Price to Earnings (P/E)	29.26	34.96	37.86	41.44	36.01	27.76	28.23	27.89	29.42	25.56
Dividend Yield	2.72%	2.49%	2.58%	2.53%	2.75%	2.46%	2.14%	2.01%	1.90%	2.19%
Earnings Yield	3.42%	2.86%	2.64%	2.41%	2.78%	3.60%	3.54%	3.59%	3.40%	3.91%
Enterprise Value to Invested Capital (EV/IC)	7.67	8.05	8.15	8.32	7.99	8.41	9.93	10.83	11.45	10.96
Enterprise Value to Revenue (EV/Rev)	3.62	3.94	3.76	3.78	3.41	3.69	4.14	4.36	4.58	4.03
Enterprise Value to EBITDA (EV/EBITDA)	18.20	21.09	21.96	19.75	17.82	17.13	17.68	18.00	18.84	16.93
Enterprise Value to EBIT (EV/EBIT)	21.58	25.17	26.47	23.28	20.98	19.81	20.26	20.55	21.52	19.38
Enterprise Value to NOPAT (EV/NOPAT)	28.35	33.10	31.99	34.40	30.61	24.90	27.18	26.83	28.04	24.64
Enterprise Value to Operating Cash Flow (EV/OCF)	21.46	27.70	23.74	22.78	19.91	19.17	22.14	22.01	23.15	19.73
Enterprise Value to Free Cash Flow (EV/FCFF)	38.53	97.49	60.02	56.34	28.18	22.86	25.19	23.65	26.88	18.28
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	7.83	10.88	20.96	28.54	21.49	8.93	14.08	18.00	10.09	14.61
Long-Term Debt to Equity	7.81	10.84	20.87	28.43	21.40	8.59	13.21	16.90	9.46	13.40
Financial Leverage	6.75	8.11	12.81	17.52	10.34	8.83	15.02	19.74	12.06	9.62
Leverage Ratio	15.47	17.32	27.66	36.58	22.16	18.22	31.42	41.04	26.42	21.61
Compound Leverage Factor	14.80	12.22	25.23	33.32	20.89	16.79	29.65	37.96	24.46	20.17
Debt to Total Capital	88.68%	91.58%	95.45%	96.61%	95.55%	89.93%	93.37%	94.74%	90.98%	93.59%
Short-Term Debt to Total Capital	0.31%	0.26%	0.40%	0.38%	0.37%	3.47%	5.78%	5.79%	5.68%	7.77%
Long-Term Debt to Total Capital	88.37%	91.32%	95.05%	96.24%	95.18%	86.46%	87.59%	88.95%	85.30%	85.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	4.63%	4.23%	4.62%	4.07%	4.55%	3.66%	4.16%	3.92%	4.32%	3.91%
Common Equity to Total Capital	6.69%	4.19%	-0.06%	-0.69%	-0.10%	6.41%	2.47%	1.34%	4.69%	2.50%
Debt to EBITDA	2.34	2.61	2.84	2.52	2.38	2.04	1.88	1.79	1.73	1.66
Net Debt to EBITDA	2.07	2.38	2.56	2.29	2.12	1.81	1.65	1.56	1.47	1.43
Long-Term Debt to EBITDA	2.33	2.60	2.82	2.51	2.37	1.96	1.76	1.68	1.62	1.52
Debt to NOPAT	3.64	4.10	4.13	4.38	4.09	2.96	2.89	2.67	2.57	2.42
Net Debt to NOPAT	3.23	3.74	3.73	3.98	3.64	2.63	2.53	2.33	2.19	2.08
Long-Term Debt to NOPAT	3.63	4.09	4.11	4.36	4.07	2.85	2.71	2.51	2.41	2.22
Altman Z-Score	5.67	5.96	5.73	5.84	5.79	6.08	6.32	6.59	6.76	6.58
Noncontrolling Interest Sharing Ratio	41.68%	43.16%	72.68%	88.09%	57.98%	42.71%	78.50%	92.60%	65.70%	45.30%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.18	1.28	1.23	1.17	1.16	1.11	1.06	1.06	1.04	0.92
Quick Ratio	0.53	0.57	0.55	0.53	0.55	0.54	0.54	0.55	0.53	0.45
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	126	-1,347	-336	-213	988	1,082	1,027	1,266	979	1,976
Operating Cash Flow to CapEx	553.71%	304.52%	450.92%	392.39%	715.53%	576.65%	540.48%	846.15%	870.90%	689.67%
Free Cash Flow to Firm to Interest Expense	3.15	-19.52	-6.23	-7.33	0.00	0.00	17.71	57.56	42.57	10.45
Operating Cash Flow to Interest Expense	24.23	9.75	13.61	24.90	0.00	0.00	11.74	45.00	50.74	6.71
Operating Cash Flow Less CapEx to Interest Expense	19.85	6.55	10.59	18.55	0.00	0.00	9.57	39.68	44.91	5.74
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.10	1.17	1.15	1.17	1.18	1.21	1.21	1.22	1.23	1.24
Accounts Receivable Turnover	12.45	12.83	11.75	11.87	12.75	12.59	11.61	11.48	12.23	12.94
Inventory Turnover	4.01	4.10	3.94	3.98	4.09	4.06	4.03	4.07	4.02	4.05
Fixed Asset Turnover	4.57	4.47	4.52	4.56	4.49	4.38	4.46	4.53	4.55	4.46
Accounts Payable Turnover	5.36	5.10	4.98	5.28	5.42	5.01	4.98	5.20	5.13	4.53
Days Sales Outstanding (DSO)	29.31	28.45	31.07	30.74	28.63	28.98	31.44	31.78	29.85	28.21
Days Inventory Outstanding (DIO)	90.98	89.04	92.60	91.78	89.27	89.96	90.68	89.73	90.87	90.12
Days Payable Outstanding (DPO)	68.04	71.64	73.25	69.13	67.40	72.92	73.35	70.25	71.08	80.52
Cash Conversion Cycle (CCC)	52.25	45.85	50.42	53.40	50.50	46.02	48.77	51.27	49.64	37.82
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,363	8,797	8,465	8,485	8,179	8,540	8,227	8,048	8,038	7,397
Invested Capital Turnover	2.20	2.22	2.30	2.31	2.31	2.24	2.37	2.42	2.48	2.52
Increase / (Decrease) in Invested Capital	598	1,413	1,007	799	-184	-257	-238	-437	-141	-1,143
Enterprise Value (EV)	64,150	70,806	68,970	70,588	65,328	71,784	81,714	87,137	92,003	81,041
Market Capitalization	56,409	62,410	60,499	62,039	57,140	63,853	73,717	79,212	84,400	73,856
Book Value per Share	$0.75	$0.48	($0.01)	($0.08)	($0.01)	$0.74	$0.28	$0.15	$0.53	$0.26
Tangible Book Value per Share	($6.16)	($5.83)	($6.38)	($6.43)	($6.29)	($5.69)	($6.03)	($6.11)	($5.86)	($5.89)
Total Capital	9,301	9,572	9,332	9,304	9,130	9,506	9,306	9,158	9,272	8,493
Total Debt	8,248	8,766	8,907	8,989	8,724	8,549	8,689	8,676	8,436	7,949
Total Long-Term Debt	8,219	8,741	8,870	8,954	8,690	8,219	8,151	8,146	7,909	7,289
Net Debt	7,310	7,991	8,040	8,170	7,773	7,583	7,610	7,566	7,202	6,853
Capital Expenditures (CapEx)	175	221	163	184	161	197	126	117	134	184
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-123	359	195	21	-162	-98	-215	-284	-466	-878
Debt-free Net Working Capital (DFNWC)	815	1,134	1,062	840	789	868	864	826	768	218
Net Working Capital (NWC)	786	1,109	1,025	805	755	538	326	296	241	-442
Net Nonoperating Expense (NNE)	42	23	257	52	57	65	60	62	62	56
Net Nonoperating Obligations (NNO)	7,310	7,991	8,040	8,170	7,773	7,583	7,610	7,566	7,202	6,853
Total Depreciation and Amortization (D&A)	134	135	128	145	144	150	150	157	150	148
Debt-free, Cash-free Net Working Capital to Revenue	-0.69%	2.00%	1.06%	0.11%	-0.85%	-0.50%	-1.09%	-1.42%	-2.32%	-4.37%
Debt-free Net Working Capital to Revenue	4.59%	6.31%	5.79%	4.50%	4.12%	4.46%	4.37%	4.13%	3.82%	1.08%
Net Working Capital to Revenue	4.43%	6.17%	5.59%	4.31%	3.95%	2.77%	1.65%	1.48%	1.20%	-2.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.74	$0.00	$0.45	$0.61	$0.86	$0.86	$0.83	$0.89	$0.90	$0.91
Adjusted Weighted Average Basic Shares Outstanding	835.21M	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M
Adjusted Diluted Earnings per Share	$0.74	$0.01	$0.45	$0.60	$0.86	$0.86	$0.83	$0.89	$0.90	$0.89
Adjusted Weighted Average Diluted Shares Outstanding	835.21M	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	835.21M	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M
Normalized Net Operating Profit after Tax (NOPAT)	724	141	671	586	804	825	789	829	838	833
Normalized NOPAT Margin	16.25%	3.05%	14.06%	12.16%	16.36%	16.66%	15.58%	16.40%	16.65%	16.84%
Pre Tax Income Margin	20.02%	2.85%	11.76%	18.39%	19.45%	19.96%	19.09%	19.97%	19.59%	20.08%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	23.30	2.71	11.39	33.59	0.00	0.00	17.67	49.64	46.30	5.63
NOPAT to Interest Expense	18.10	0.95	12.42	20.22	0.00	0.00	13.61	37.69	36.44	4.41
EBIT Less CapEx to Interest Expense	18.93	-0.49	8.37	27.24	0.00	0.00	15.50	44.32	40.48	4.66
NOPAT Less CapEx to Interest Expense	13.73	-2.25	9.40	13.88	0.00	0.00	11.44	32.38	30.62	3.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	80.59%	85.97%	95.78%	103.05%	99.42%	71.24%	63.29%	58.91%	58.74%	58.68%
Augmented Payout Ratio	139.82%	152.47%	156.41%	166.89%	173.99%	117.19%	115.88%	111.06%	109.17%	115.71%

Frequently Asked Questions About Colgate-Palmolive's Financials

When does Colgate-Palmolive's fiscal year end?

According to the most recent income statement we have on file, Colgate-Palmolive's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Colgate-Palmolive's net income changed over the last 9 years?

Colgate-Palmolive's net income appears to be on an upward trend, with a most recent value of $3.05 billion in 2024, rising from $1.55 billion in 2015. The previous period was $2.46 billion in 2023.

What is Colgate-Palmolive's operating income?

Colgate-Palmolive's total operating income in 2024 was $4.27 billion, based on the following breakdown:

Total Gross Profit: $12.16 billion
Total Operating Expenses: $7.89 billion

How has Colgate-Palmolive revenue changed over the last 9 years?

Over the last 9 years, Colgate-Palmolive's total revenue changed from $16.03 billion in 2015 to $20.10 billion in 2024, a change of 25.4%.

How much debt does Colgate-Palmolive have?

Colgate-Palmolive's total liabilities were at $15.50 billion at the end of 2024, a 0.4% increase from 2023, and a 29.4% increase since 2015.

How much cash does Colgate-Palmolive have?

In the past 9 years, Colgate-Palmolive's cash and equivalents has ranged from $726 million in 2018 to $1.54 billion in 2017, and is currently $1.10 billion as of their latest financial filing in 2024.

How has Colgate-Palmolive's book value per share changed over the last 9 years?

Over the last 9 years, Colgate-Palmolive's book value per share changed from -0.33 in 2015 to 0.26 in 2024, a change of -177.8%.

Remove Ads

Related Companies

This page (NYSE:CL) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Financials

Frequently Asked Questions About Colgate-Palmolive's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Colgate-Palmolive (CL) Financials

Annual Income Statements for Colgate-Palmolive

Quarterly Income Statements for Colgate-Palmolive

Annual Cash Flow Statements for Colgate-Palmolive

Quarterly Cash Flow Statements for Colgate-Palmolive

Annual Balance Sheets for Colgate-Palmolive

Quarterly Balance Sheets for Colgate-Palmolive

Annual Metrics and Ratios for Colgate-Palmolive

Quarterly Metrics and Ratios for Colgate-Palmolive

Frequently Asked Questions About Colgate-Palmolive's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools